Assay of antioxidant capacity of human plasma and CSF in aging and disease
- PMID: 12671311
Assay of antioxidant capacity of human plasma and CSF in aging and disease
Abstract
Oxidative damage to DNA and other macromolecules accumulates with age and has been postulated to be one of the major forms of endogenous damage leading to aging and has been implicated also in initiation of cancer and over a hundred other diseases. The human body has developed an antioxidant (AOX) defense system which contains enzymatic, metal chelating, and free radical scavenging properties. Thus, it is essential to consider the concentration of all AOXs in plasma and CSF when investigating the relationship between diet, oxidative stress, and disease. In the present study a luminometric TRAP-method (total peroxyl radical-trapping potential) was used to determine the activity of all chain breaking AOXs in several clinical states. We have measured TRAP of plasma, cerebrospinal fluid (CSF) and of low density lipoprotein (LDL, TRAPLDL), and the concentrations of main AOX-components (uric acid, protein SH-groups, alpha-tocopherol, ascorbic acid, ubiquinone and the fraction of unknown antioxidants) to study the effect of: 1) aging, 2) acute infection, 3) diabetes, 4) immobilization and 5) cancer. TRAP of CSF is five times lower than of plasma, mainly due to the low urate concentration in CSF. We have observed that plasma antioxidant defenses respond to the basic metabolic rate and the challenges caused by physiological or pathological stress: i) in a healthy normal population TRAP and TRAPLDL change with age and a substantial proportion of TRAP cannot be attributed to any known AOXs thus indicating the existence of unmeasured an unidentified antioxidant(s); ii) during acute infection and immobilization the exogenous AOXs (vitamin C and E) remained unchanged, whereas the activity of unidentified AOXs of plasma declined sharply; iii) in those NIDDM patients with coronary heart disease plasma TRAP is reduced. In conclusion, TRAP has revealed important information for evaluating the AOX status of human plasma, CSF and LDL. According to our studies, important, possibly endogenous AOXs still remain to be identified.
Similar articles
-
Effects of surgical removal of lung cancer on total plasma antioxidant capacity in lung cancer patients.J Exp Clin Cancer Res. 1998 Jun;17(2):219-25. J Exp Clin Cancer Res. 1998. PMID: 9700584 Clinical Trial.
-
Quantification of the nonenzymatic fast and slow TRAP in a postaddition assay in human seminal plasma and the antioxidant contributions of various seminal compounds.J Androl. 2000 Nov-Dec;21(6):913-20. J Androl. 2000. PMID: 11105918
-
Human plasma antioxidant capacity during radiotherapy for lung cancer: a clinical study.J Exp Clin Cancer Res. 1998 Sep;17(3):325-30. J Exp Clin Cancer Res. 1998. PMID: 9894770 Clinical Trial.
-
Vitamin E in neurodegenerative disorders: Alzheimer's disease.Ann N Y Acad Sci. 2004 Dec;1031:249-62. doi: 10.1196/annals.1331.025. Ann N Y Acad Sci. 2004. PMID: 15753151 Review.
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
Cited by
-
Effect of in vitro exposure of human serum to 3-butyl-1-phenyl-2-(phenyltelluro)oct-en-1-one on oxidative stress.Mol Cell Biochem. 2009 Dec;332(1-2):127-34. doi: 10.1007/s11010-009-0182-6. Epub 2009 Jun 25. Mol Cell Biochem. 2009. PMID: 19554424
-
Urate as a predictor of the rate of clinical decline in Parkinson disease.Arch Neurol. 2009 Dec;66(12):1460-8. doi: 10.1001/archneurol.2009.247. Arch Neurol. 2009. PMID: 19822770 Free PMC article. Clinical Trial.
-
What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson's Disease Patients and Healthy Subjects with Parkinson's-Associated LRRK2 Mutations?J Parkinsons Dis. 2019;9(3):467-488. doi: 10.3233/JPD-191630. J Parkinsons Dis. 2019. PMID: 31322581 Free PMC article. Review.
-
Increased Oxidative Stress Markers in Cerebrospinal Fluid from Healthy Subjects with Parkinson's Disease-Associated LRRK2 Gene Mutations.Front Aging Neurosci. 2017 Apr 3;9:89. doi: 10.3389/fnagi.2017.00089. eCollection 2017. Front Aging Neurosci. 2017. PMID: 28420983 Free PMC article.
-
Serotonin as a putative scavenger of hypohalous acid in the brain.Biochim Biophys Acta. 2016 Apr;1862(4):651-661. doi: 10.1016/j.bbadis.2015.12.012. Epub 2015 Dec 14. Biochim Biophys Acta. 2016. PMID: 26699077 Free PMC article.